Seroxat Tab 20 mg

Valsts: Jordānija

Valoda: angļu

Klimata pārmaiņas: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Aktīvā sastāvdaļa:

Paroxetine 20 mg

Pieejams no:

مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd

ATĶ kods:

N06AB05

SNN (starptautisko nepatentēto nosaukumu):

Paroxetine 20 mg

Deva:

20 mg

Vienības iepakojumā:

30

Ražojis:

Delpharma Ponzan Spolka Akcyjna (بولندا)

Produktu pārskats:

7.29 :سعر الجمهور + الضريبة

Lietošanas instrukcija

Seroxat™ 20 mg
Film-coated tablets
Paroxetine
NAME OF MEDICINAL PRODUCT
Seroxat 20 mg film-coated tablets.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 20 mg paroxetine (as paroxetine
hydrochloride hemihydrate).
For the full list of excipients, see “List of excipients”.
PHARMACEUTICAL FORM
White, film-coated, oval shaped biconvex tablets debossed with
“20” on one side and a break bar on the other.
The 20 mg tablet can be divided into equal doses if required.
CLINICAL PARTICULARS
Therapeutic indications
Treatment of
-
Major Depressive Episode
-
Obsessive Compulsive Disorder
-
Panic Disorder with and without agoraphobia
-
Social Anxiety Disorders/Social phobia
- Generalised Anxiety Disorder
-
Post-Traumatic Stress Disorder
Posology and method of administration
Posology
MAJOR DEPRESSIVE EPISODE
The recommended dose is 20 mg daily. In general, improvement in
patients starts after one week but may only become evident from the
second
week of therapy.
As with all antidepressant medicinal products, dosage should be
reviewed and adjusted if necessary within 3 to 4 weeks of initiation
of therapy
and thereafter as judged clinically appropriate. In some patients,
with insufficient response to 20 mg, the dose may be increased
gradually up to
a maximum of 50 mg a day in 10 mg steps according to the patient’s
response.
Patients with depression should be treated for a sufficient period of
at least 6 months to ensure that they are free from symptoms.
OBSESSIVE COMPULSIVE DISORDER
The recommended dose is 40 mg daily. Patients should start on 20
mg/day and the dose may be increased gradually in 10 mg increments to
the
recommended dose. If after some weeks on the recommended dose
insufficient response is seen some patients may benefit from having
their
dose increased gradually up to a maximum of 60 mg/day.
Patients with OCD should be treated for a sufficient period to ensure
that they are free from symptoms. This period may be several months or
even longer (see “Pharmacodynamic properties�